| Schedule of direct and indirect voting rights in subsidiaries and other investments |
| | | | | 2025 | | | Company’s | | | voting | | | rights | | | % | Subsidiaries | | | Aptuit Global LLC, Princeton, USA | | 100 | Aptuit (Verona) SRL, Verona, Italy | | 100 | Aptuit (Oxford) Ltd., Abingdon, UK | | 100 | Cyprotex Discovery Ltd., Manchester, UK | | 100 | Cyprotex Ltd., Manchester, UK | | 100 | Cyprotex US, LLC., Framingham, USA | | 100 | Evotec (France) SAS, Toulouse, France | | 100 | Evotec ID (Lyon) SAS, Marcy l’Étoile, France | | 100 | Evotec (Hamburg) GmbH, Hamburg, Germany | | 100 | Evotec GT GmbH, Orth an der Donau, Austria* | | 100 | Evotec (India) Private Limited, Thane, India* | | 100 | Evotec International GmbH, Hamburg, Germany | | 100 | Evotec (UK) Ltd., Abingdon, UK | | 100 | Evotec (US), Inc., Princeton, USA | | 100 | Just - Evotec Biologics, Inc., Seattle, USA | | 100 | Evotec (Modena) Srl, Medolla, Italy | | 100 | NephThera GmbH, Hamburg, Germany | | 100 | Evotec Asia Pte. Ltd., Shenton, Singapore | | 100 |
| | | | | 2025 | | | Company’s | | | voting | | | rights | | | % | Associates | | | Breakpoint Therapeutics GmbH, Hamburg, Germany | | 34.03 | Centauri Therapeutics Ltd., Cheshire, UK | | 22.18 | EIR Biotherapies S.r.l., Mirandola (MO), Italy | | 24.66 | Eternygen GmbH, Berlin, Germany* | | 24.97 | Quantro Therapeutics GmbH, Vienna, Austria | | 38.79 | TAG Therapeutics GmbH, Vienna, Austria | | 20.16 | Topas Therapeutics GmbH, Hamburg, Germany | | 23.86 | | | | Other Investments | | | Aeovian Pharmaceuticals Inc., San Francisco, USA | | 2.32 | ArgoBio SAS, Paris, France | | 8.17 | Aurobac Therapeutics SAS, Lyon, France | | 12.50 | Autobahn Labs, LLC, Palo Alto, CA USA | | 10.53 | Blacksmith Medicines Inc., San Diego, CA USA | | 17.97 | Cajal Neuroscience Inc., Seattle, USA | | 1.18 | Carma Fund I, Munich, Germany | | 10.00 | Celmatix Inc., New York, USA | | 7.47 | Curie Bio LLC, Boston, USA | | 0.10 | Curie Bio Seed Fund I LP, Boston, USA | | 2.83 | Extend S.r.l., Rome, Italy | | 9.10 | Fibrocor LLP, Toronto, Canada | | 16.26 | Fibrocor Therapeutics, Inc., Toronto, Canada | | 7.65 | IMIDomics Inc., San Rafael, CA, USA | | 6.64 | Immunitas Therapeutics Inc.*, Waltham, USA | | 5.54 | Leon Nanodrugs GmbH, Munich, Germany | | 3.99 | Mission BioCapital V LP, Cambridge, USA | | 3.64 | Pluristyx Inc., Seattle, USA | | 3.79 | Sernova Corp., Ontario, Canada | | 4.73 | Thelior Bio, Oxford, UK | | 1.18 | Tubulis GmbH, Munich, Germany | | 3.33 | Verto Therapeutics Inc., Boston, USA | | 4.16 |
|